All Guidance articles
View all pages of the same content type.
-
GuidanceREACHReady guidance: Article 26 Inquiry
The aim of REACH is to improve the protection of human health and the environment. In order to understand the risks of chemicals and know how to use them safely, the intrinsic hazardous properties of those substances must first be identified. Key to the philosophy of REACH is the importance ...
-
-
GuidanceGuidance for writing and receiving exposure scenarios
ECHA guidance on information requirements and CAS – Part D: Framework for exposure assessment (August 2016) This document provides guidance on how to carry out an exposure assessment to determine the conditions of safe use for all the uses of a substance registered under REACH. Find out more Annotated templates ...
-
GuidanceCompiling Extended Safety Data Sheets for Substances
Tips and recommendations for substances
-
-
GuidanceProduct Stewardship Guidance
The Responsible Care of products through all stages of their life cycle
-
-
GuidanceDeveloping and Implementing Drug and Alcohol Policies
It is fundamental that health, safety and wellbeing considerations form the core of the drug and alcohol Policy. The application of the policy should be based on due consideration of these factors.
-
GuidanceMental Health and Mental Well-being Policy
Part of the CIA’s Health & Well-being leadership strategy series - Helping members achieve sustainable healthy workplaces
-
GuidanceDeveloping and Implementing a Menopause Policy
Part of the CIA’s Health & Well-being leadership strategy series - Helping members achieve sustainable healthy workplaces.
-
GuidanceWorking with EU member States
Our sector needed tariff-free trade, minimal border delays, regulatory consistency and continued access to skilled people. Members of the Chemical Industries Association (CIA) have examined the issue of Brexit and our relations with the European Union in great detail.
-
GuidanceSustainability Reporting Disclosures
Guidance on sustainable finance and taxonomy-related reporting and disclosures.
